{"id":5518,"date":"2017-04-19T09:25:18","date_gmt":"2017-04-19T12:25:18","guid":{"rendered":"https:\/\/prodoctor.net\/blog\/?p=5518"},"modified":"2021-06-25T14:35:51","modified_gmt":"2021-06-25T17:35:51","slug":"medicamentos-para-cancer-e-hemorragias-aprovados","status":"publish","type":"post","link":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/","title":{"rendered":"Medicamentos para c\u00e2ncer e hemorragias aprovados"},"content":{"rendered":"<p>Dois novos medicamentos, <strong>Blincyto (blinatumomab) e Praxbind (idarucizumab)<\/strong>, destinados respectivamente para combater <strong>c\u00e2ncer e hemorragias<\/strong>, foram aprovados na \u00faltima segunda-feira (17) pela Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa).<\/p>\n<p><strong>Eles ainda n\u00e3o existiam no Brasil<\/strong> e o primeiro recebeu sinal positivo com indica\u00e7\u00e3o para o tratamento de adultos com <strong>Leucemia Linfobl\u00e1stica Aguda (LLA)<\/strong> de linhagem B recidivada ou refrat\u00e1ria com cromossomo Philadelphia negativo.<\/p>\n<p>J\u00e1 o segundo medicamento tem como principal fun\u00e7\u00e3o <strong>interromper os efeitos anticoagulantes do Pradaxa<\/strong>, medicamento utilizado em cirurgias, evitando que os pacientes tenham <strong>sangramentos que coloquem suas vidas em risco<\/strong>.<\/p>\n<h3>Blincyto (blinatumomab)<\/h3>\n<p>A <strong>leucemia linfobl\u00e1stica aguda \u00e9 um tipo de c\u00e2ncer<\/strong> que ataca as c\u00e9lulas brancas do organismo, que fazem parte do sistema de defesa do organismo. O Blincyto foi o primeiro anti CD-19 a receber do FDA (Food and Drug Administration) a designa\u00e7\u00e3o de terapia inovadora e a obter revis\u00e3o priorit\u00e1ria. <strong>Sua aprova\u00e7\u00e3o foi concedida no dia 3 de dezembro<\/strong> e ele \u00e9 comercializado pela Amgen Inc.<\/p>\n<p>Sua efic\u00e1cia e seguran\u00e7a foram avaliadas e comprovadas <strong>durante um estudo cl\u00ednico com 185 adultos<\/strong> com LLA cromossomo Philadelphia de c\u00e9lulas B, em recidiva ou refrat\u00e1rios \u00e0 terapia anterior. Eles foram tratados com o Blincyto <strong>durante pelo menos quatro semanas atrav\u00e9s de infus\u00e3o<\/strong> e os resultados revelaram que <strong>32% deles n\u00e3o tinham nenhuma evid\u00eancia<\/strong> de doen\u00e7a (remiss\u00e3o completa) ap\u00f3s um seguimento m\u00e9dio de aproximadamente 6-7 meses.<\/p>\n<p>Em comunicado \u00e0 imprensa, o diretor do Escrit\u00f3rio de Hematologia e Oncologia do FDA para Avalia\u00e7\u00e3o e Pesquisa de Drogas, Richard Pazdur,<strong> atestou o potencial do novo medicamento<\/strong>. Segundo ele, \u201c\u00e9 um tratamento com um mecanismo de a\u00e7\u00e3o \u00fanico, <strong>particularmente promissor para pacientes com esse tipo de leucemia<\/strong>\u201d. Assim, \u201co FDA trabalhou de forma proativa com o patrocinador para facilitar a aprova\u00e7\u00e3o deste novo agente\u201d.<\/p>\n<p>Dentre os<strong> efeitos colaterais mais comuns<\/strong> observados em participantes tratados com o medicamento est\u00e3o relacionados: febre, dor de cabe\u00e7a, incha\u00e7o dos tecidos (edema perif\u00e9rico), neutropenia febril, n\u00e1useas, hipocalemia, fadiga, constipa\u00e7\u00e3o, diarreia e tremor.<\/p>\n<h3>Praxbind (idarucizumab)<\/h3>\n<p>O uso do Praxbind \u00e9 indicado para um tratamento que reverte de forma r\u00e1pida e espec\u00edfica <strong>os efeitos anticoagulantes do Pradaxa<\/strong> (etexilato de dabigatrana) em casos de cirurgia, <strong>procedimentos de urg\u00eancia ou de emerg\u00eancia<\/strong> em situa\u00e7\u00f5es de risco de vida ou hemorragia descontrolada. O idarucizumab \u00e9 um <strong>fragmento de anticorpo monoclonal<\/strong>, que ao ser injetado na circula\u00e7\u00e3o neutraliza a dabigatrana atrav\u00e9s de uma liga\u00e7\u00e3o direta, <strong>impedindo a sua a\u00e7\u00e3o anticoagulante<\/strong>.<\/p>\n<p>Um dos \u00faltimos estudos antes da aprova\u00e7\u00e3o foi realizado com <strong>pacientes necessitando de anticoagula\u00e7\u00e3o<\/strong>. Estes utilizavam dabigatrana e apresentaram sangramento como efeito colateral ou tiveram de ser submetidos a uma cirurgia de emerg\u00eancia. O idarucizumab foi aplicado nestes pacientes e em<strong> 90% dos casos reverteu os efeitos anticoagulantes da dabigatrana<\/strong> em at\u00e9 quatro horas ap\u00f3s serem administrados.<\/p>\n<p>Segundo o vice-presidente da \u00e1rea de Medicina, \u00e1rea Terap\u00eautica Cardiovascular da Boehringer Ingelheim, J\u00f6rg Kreuzer, &#8220;com esta aprova\u00e7\u00e3o, a <strong>Boehringer Ingelheim est\u00e1 novamente na lideran\u00e7a da evolu\u00e7\u00e3o<\/strong> dos cuidados de anticoagula\u00e7\u00e3o, como fizemos com a introdu\u00e7\u00e3o do Pradaxa. E embora antecipemos que o Praxbind ser\u00e1 raramente utilizado na pr\u00e1tica cl\u00ednica, a disponibilidade deste agente reversor espec\u00edfico <strong>pode agora dar aos m\u00e9dicos e pacientes mais confian\u00e7a na escolha do Pradaxa<\/strong>&#8220;.<\/p>\n<p>O Pradaxa foi aprovado pelo FDA em 2010<strong> para prevenir o Acidente Vascular Cerebral e co\u00e1gulos sangu\u00edneos<\/strong> sist\u00eamicos em pacientes com fibrila\u00e7\u00e3o arterial, bem como para o tratamento e preven\u00e7\u00e3o da trombose venosa profunda e embolia pulmonar.<\/p>\n<p>Os <strong>principais efeitos colaterais observados<\/strong> no uso do idarucizumab foram cefaleia, febre, constipa\u00e7\u00e3o, hipocalemia, confus\u00e3o mental e pneumonia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dois novos medicamentos, Blincyto (blinatumomab) e Praxbind (idarucizumab), destinados respectivamente para combater c\u00e2ncer e hemorragias, foram aprovados na \u00faltima&#8230;<\/p>\n","protected":false},"author":1,"featured_media":19827,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[415],"tags":[],"class_list":["post-5518","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicamentos-e-farmacia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medicamentos para c\u00e2ncer e hemorragias aprovados<\/title>\n<meta name=\"description\" content=\"Dois medicamentos biol\u00f3gicos novos que ainda n\u00e3o existiam no Brasil foram liberados pela Anvisa, o Blincyto (blinatumomabe) e o Praxbind (idarucizumabe).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medicamentos para c\u00e2ncer e hemorragias aprovados\" \/>\n<meta property=\"og:description\" content=\"Dois medicamentos biol\u00f3gicos novos que ainda n\u00e3o existiam no Brasil foram liberados pela Anvisa, o Blincyto (blinatumomabe) e o Praxbind (idarucizumabe).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog ProDoctor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/prodoctorsoftware\" \/>\n<meta property=\"article:published_time\" content=\"2017-04-19T12:25:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-25T17:35:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"770\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ProDoctor Software\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@prodoctorsoft\" \/>\n<meta name=\"twitter:site\" content=\"@prodoctorsoft\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"ProDoctor Software\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/\"},\"author\":{\"name\":\"ProDoctor Software\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/8878914b17cd360e7ec0ddee1ed8c544\"},\"headline\":\"Medicamentos para c\u00e2ncer e hemorragias aprovados\",\"datePublished\":\"2017-04-19T12:25:18+00:00\",\"dateModified\":\"2021-06-25T17:35:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/\"},\"wordCount\":642,\"publisher\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg\",\"articleSection\":[\"Medicamentos e Farm\u00e1cia\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/\",\"url\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/\",\"name\":\"Medicamentos para c\u00e2ncer e hemorragias aprovados\",\"isPartOf\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg\",\"datePublished\":\"2017-04-19T12:25:18+00:00\",\"dateModified\":\"2021-06-25T17:35:51+00:00\",\"description\":\"Dois medicamentos biol\u00f3gicos novos que ainda n\u00e3o existiam no Brasil foram liberados pela Anvisa, o Blincyto (blinatumomabe) e o Praxbind (idarucizumabe).\",\"breadcrumb\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#primaryimage\",\"url\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg\",\"contentUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg\",\"width\":770,\"height\":400,\"caption\":\"Brasil questiona requisitos para patente de cura da hepatite C\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/prodoctor.net\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medicamentos para c\u00e2ncer e hemorragias aprovados\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#website\",\"url\":\"https:\/\/prodoctor.net\/blog\/\",\"name\":\"Blog ProDoctor\",\"description\":\"Tudo sobre o mundo da Sa\u00fade\",\"publisher\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prodoctor.net\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\",\"name\":\"ProDoctor Software S\/A\",\"url\":\"https:\/\/prodoctor.net\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png\",\"contentUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png\",\"width\":2014,\"height\":485,\"caption\":\"ProDoctor Software S\/A\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/prodoctorsoftware\",\"https:\/\/x.com\/prodoctorsoft\",\"https:\/\/www.instagram.com\/prodoctorsoftware\/\",\"https:\/\/www.linkedin.com\/company\/prodoctor-software-ltda\",\"https:\/\/www.youtube.com\/channel\/UCIWuDLsVtIpX-PEqQn1pNlw\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/8878914b17cd360e7ec0ddee1ed8c544\",\"name\":\"ProDoctor Software\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a67bdb10f2e6695f7ae356a84deeaf10b545567f0ac054e9bfe8ec56e86317ec?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a67bdb10f2e6695f7ae356a84deeaf10b545567f0ac054e9bfe8ec56e86317ec?s=96&d=mm&r=g\",\"caption\":\"ProDoctor Software\"},\"sameAs\":[\"http:\/\/prodoctor.net\",\"https:\/\/x.com\/prodoctorsoft\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medicamentos para c\u00e2ncer e hemorragias aprovados","description":"Dois medicamentos biol\u00f3gicos novos que ainda n\u00e3o existiam no Brasil foram liberados pela Anvisa, o Blincyto (blinatumomabe) e o Praxbind (idarucizumabe).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/","og_locale":"pt_BR","og_type":"article","og_title":"Medicamentos para c\u00e2ncer e hemorragias aprovados","og_description":"Dois medicamentos biol\u00f3gicos novos que ainda n\u00e3o existiam no Brasil foram liberados pela Anvisa, o Blincyto (blinatumomabe) e o Praxbind (idarucizumabe).","og_url":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/","og_site_name":"Blog ProDoctor","article_publisher":"https:\/\/www.facebook.com\/prodoctorsoftware","article_published_time":"2017-04-19T12:25:18+00:00","article_modified_time":"2021-06-25T17:35:51+00:00","og_image":[{"width":770,"height":400,"url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg","type":"image\/jpeg"}],"author":"ProDoctor Software","twitter_card":"summary_large_image","twitter_creator":"@prodoctorsoft","twitter_site":"@prodoctorsoft","twitter_misc":{"Escrito por":"ProDoctor Software","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#article","isPartOf":{"@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/"},"author":{"name":"ProDoctor Software","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/8878914b17cd360e7ec0ddee1ed8c544"},"headline":"Medicamentos para c\u00e2ncer e hemorragias aprovados","datePublished":"2017-04-19T12:25:18+00:00","dateModified":"2021-06-25T17:35:51+00:00","mainEntityOfPage":{"@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/"},"wordCount":642,"publisher":{"@id":"https:\/\/prodoctor.net\/blog\/#organization"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#primaryimage"},"thumbnailUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg","articleSection":["Medicamentos e Farm\u00e1cia"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/","url":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/","name":"Medicamentos para c\u00e2ncer e hemorragias aprovados","isPartOf":{"@id":"https:\/\/prodoctor.net\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#primaryimage"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#primaryimage"},"thumbnailUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg","datePublished":"2017-04-19T12:25:18+00:00","dateModified":"2021-06-25T17:35:51+00:00","description":"Dois medicamentos biol\u00f3gicos novos que ainda n\u00e3o existiam no Brasil foram liberados pela Anvisa, o Blincyto (blinatumomabe) e o Praxbind (idarucizumabe).","breadcrumb":{"@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#primaryimage","url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg","contentUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg","width":770,"height":400,"caption":"Brasil questiona requisitos para patente de cura da hepatite C"},{"@type":"BreadcrumbList","@id":"https:\/\/prodoctor.net\/blog\/medicamentos-para-cancer-e-hemorragias-aprovados\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/prodoctor.net\/blog\/"},{"@type":"ListItem","position":2,"name":"Medicamentos para c\u00e2ncer e hemorragias aprovados"}]},{"@type":"WebSite","@id":"https:\/\/prodoctor.net\/blog\/#website","url":"https:\/\/prodoctor.net\/blog\/","name":"Blog ProDoctor","description":"Tudo sobre o mundo da Sa\u00fade","publisher":{"@id":"https:\/\/prodoctor.net\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prodoctor.net\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/prodoctor.net\/blog\/#organization","name":"ProDoctor Software S\/A","url":"https:\/\/prodoctor.net\/blog\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png","contentUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png","width":2014,"height":485,"caption":"ProDoctor Software S\/A"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/prodoctorsoftware","https:\/\/x.com\/prodoctorsoft","https:\/\/www.instagram.com\/prodoctorsoftware\/","https:\/\/www.linkedin.com\/company\/prodoctor-software-ltda","https:\/\/www.youtube.com\/channel\/UCIWuDLsVtIpX-PEqQn1pNlw"]},{"@type":"Person","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/8878914b17cd360e7ec0ddee1ed8c544","name":"ProDoctor Software","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a67bdb10f2e6695f7ae356a84deeaf10b545567f0ac054e9bfe8ec56e86317ec?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a67bdb10f2e6695f7ae356a84deeaf10b545567f0ac054e9bfe8ec56e86317ec?s=96&d=mm&r=g","caption":"ProDoctor Software"},"sameAs":["http:\/\/prodoctor.net","https:\/\/x.com\/prodoctorsoft"]}]}},"taxonomy_info":{"category":[{"value":415,"label":"Medicamentos e Farm\u00e1cia"}]},"featured_image_src_large":["https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/Medicamento-pode-prevenir-infertilidade.jpg",770,400,false],"author_info":{"display_name":"ProDoctor Software","author_link":"https:\/\/prodoctor.net\/blog\/author\/redesocialprodoctor-net\/"},"comment_info":0,"category_info":[{"term_id":415,"name":"Medicamentos e Farm\u00e1cia","slug":"medicamentos-e-farmacia","term_group":0,"term_taxonomy_id":415,"taxonomy":"category","description":"","parent":0,"count":132,"filter":"raw","cat_ID":415,"category_count":132,"category_description":"","cat_name":"Medicamentos e Farm\u00e1cia","category_nicename":"medicamentos-e-farmacia","category_parent":0}],"tag_info":false,"_links":{"self":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/5518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/comments?post=5518"}],"version-history":[{"count":3,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/5518\/revisions"}],"predecessor-version":[{"id":9698,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/5518\/revisions\/9698"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/media\/19827"}],"wp:attachment":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/media?parent=5518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/categories?post=5518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/tags?post=5518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}